Follow the Kopran Limited stock price and the full directors' dealings record of the company, a listed issuer based in India. Shares trade on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Kopran Limited has logged 8 insider filings. Market capitalisation: €9.2bn. The latest transaction was filed on 8 January 2025 (Purchase). Among the most active insiders: Mridula Somani. All data is openly available.
8
Insider Decl.
n/a
Thresholds
€147,806
8 ops.
Buy Volume
n/a
n/a
Sell Volume
9Σ signal
Buys €147,806n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,117 of 29,063 companies
41.6
score / 100
Value
39
Quality
44
FCF yld-0.0%
Earn yld2.8%
EV/EBITDA17.7x
ROE4.9%
Gross mgn33%
Net mgn3.8%
Debt/EBITDA2.5x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
10,000 shares@ ₹149.2050.0% of flowEquity SharesSEBI:0b05b9dc7539def83a9596f742e79d87c51c67a4
8 of 8 declarations
Acerca de Kopran Limited
Kopran Limited es una empresa que opera en el sector de la salud y farmacéutico, especializada en la fabricación de productos farmacéuticos. Cotiza en el XBOM.